Showing results (21-30 of 116) with videos related to
Sort By:
Pageof 12
The Journal of Rheumatology|April 17, 2009
Utilization trends of tumor necrosis factor inhibitors among patients with rheumatoid arthritis in a United States observational cohort studySusan J Lee, Hong Chang, Yusuf Yazici, et al.Arthritis Care & Research|June 7, 2013
Patient perspectives on achieving treat-to-target goals: a critical examination of patient-reported outcomesJeffrey R Curtis, Ying Shan, Leslie Harrold, et al.Modern Rheumatology|April 28, 2017
Design characteristics of the Corrona Japan rheumatoid arthritis registryHisashi Yamanaka, Mitsumasa Kishimoto, Dimitrios A Pappas, et al.The American Journal of Medicine|October 27, 2004
Reimbursement denial and reversal by health plans at a university hospitalJeffrey D Greenberg, Donald R Hoover, Ranita Sharma, et al.Rheumatology and Therapy|October 25, 2018
Tumor Necrosis Factor Inhibitor Discontinuation in Patients with Ankylosing Spondylitis: An Observational Study From the US-Based Corrona RegistryPhilip J Mease, Désirée van der Heijde, Chitra Karki, et al.Rheumatology and Therapy|September 19, 2019
Comparative Disease Burden in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, or Axial Spondyloarthritis: Data from Two Corrona RegistriesPhilip J Mease, Mei Liu, Sabrina Rebello, et al.Arthritis and Rheumatism|February 8, 2005
Effect of cardiovascular comorbidities and concomitant aspirin use on selection of cyclooxygenase inhibitor among rheumatologistsJeffrey D Greenberg, Clifton O Bingham, Steven B Abramson, et al.Arthritis Care & Research|September 29, 2011
Thresholds in disease activity for switching biologics in rheumatoid arthritis patients: experience from a large U.S. cohortJie Zhang, Ying Shan, George Reed, et al.Journal of the American Academy of Dermatology|October 21, 2017
Characterization of disease burden, comorbidities, and treatment use in a large, US-based cohort: Results from the Corrona Psoriasis RegistryBruce Strober, Chitra Karki, Marc Mason, et al.RMD Open|January 29, 2016
Comparative effectiveness of biologic monotherapy versus combination therapy for patients with psoriatic arthritis: results from the Corrona registryPhilip J Mease, David H Collier, Katherine C Saunders, et al.Pageof 12